Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer

by Veronica Rendo, Snehangshu Kundu, Natallia Rameika, Viktor Ljungström, Richard Svensson, Kimmo Palin, Lauri Aaltonen, Ivaylo Stoimenov, Tobias Sjöblom
Published 2020-12-01